Skip to page content

StoriesMore

Arvin Ganesen
News
Jeff Karp
News
copyrightandyryan 1020300 b 720 2
News
Investors riding chaotic, descending arrow
News
Allium SJ, SM Mill photo edit
News
inno madness 2024_TBBJ
News
doroni hummingbird
News
Michael Stonebraker
News
BSU BlogNick C BSU 100 (1)
News
Boston Speaks Up Cam Brown
Profiles
14 Motif FoodWorks Phyical Lab Credit Webb Chappell
Profiles
Aleia Bucci, Jeremiah Pate
Profiles
Guy Hudson
Profiles
Boston Speaks Up Aisha Chottani
Profiles
Waeve Founders
Profiles
Boston Speaks Up Mike Salguero
Profiles
Pamela Shaddock, co-founder and Dianne Austin, CEO
Profiles
Jake Tamarkin, CEO of Everyday Life Insurance
Profiles
Crumpled one dollar bills on blue background
Inno Insights
Sports gambling
Inno Insights
Venture capital
Inno Insights
Compensation
Inno Insights
Financial growth
Inno Insights
Proptech startups
Inno Insights
Corporate investments
Inno Insights
Sam Bankman-Fried, FTX
Inno Insights
Hand grasping at fluttering money
Inno Insights

More

Mar
20
TBJ

See All Events

Want to stay ahead of who & what is next? Sent daily, the Beat is your definitive look at Boston’s innovation economy, offering news, analysis & more on the people, companies & ideas driving your city forward. Follow the Beat.

Sign Up
Mar
20
TBJ

See All Events

SpotlightMore

See More
See More
See More
See More
See More
See More

Thought Leadership from our Partners

March 18, 2024

The apartments are all income-restricted, with 80% of the units filled by residents who have vouchers that lower their rent further. It's a model that public officials want to see replicated elsewhere.

March 18, 2024

Gov. Maura Healey filed a nearly $535 million supplemental budget to address funding shortfalls for "vital" human services and early education programs and to shore up funding for safety-net hospitals.

March 18, 2024

This decision marks the first FDA-approved treatment for children with a rare genetic disease called metachromatic leukodystrophy (MLD) and Orchard's entry into the U.S. drug market.

March 18, 2024

Waltham payment platform company BlueSnap has named the founder of another fintech company its new CEO.

March 18, 2024

The agreement includes an initial tranche totaling $75 million, and additional capital dependent on bluebird bio hitting certain commercial milestones on the rollout of its FDA-approved gene therapies.